Physician profile
Eva Giro
NPI 1104821420
$9,733.23
in general payments reported to CMS, 2019-2025
47 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,040 · 2020: $1,567 · 2021: $1,676 · 2022: $1,059 · 2023: $1,362 · 2024: $1,624 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,386 · Education: $5.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,385.93 |
| Education | $5.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,691.21 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $1,253.45 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $753.88 | 2021-2025 | |
| Amarin Pharma, INC. | $748.60 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $647.44 | 2019-2025 | Jardiance, Ofev |
| Lilly USA, LLC | $535.71 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $498.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $484.38 | 2019-2025 | |
| Exact Sciences Corporation | $395.92 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $278.69 | 2019-2021 | |
| Boston Scientific Corporation | $222.53 | 2020-2025 | Watchman Access System |
| Xeris Pharmaceuticals, INC. | $195.04 | 2023-2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $191.65 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $176.99 | 2019-2021 | |
| Astellas Pharma US INC | $170.54 | 2022-2024 | Veozah, Myrbetriq |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Giro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.